Evidence map›Paper›PMID 36671934›Full record

ReviewBiosensors2023

Application of Various Optical and Electrochemical Nanobiosensors for Detecting Cancer Antigen 125 (CA-125): A Review.

Mehrab Pourmadadi, Ali Moammeri, Amin Shamsabadipour, Yasamin Farahanian Moghaddam, Abbas Rahdar, Sadanand Pandey

Abstract readReview
In one paragraph

Review in Biosensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. [Clinical characteristics and prognosis analysis of 108 cases of recurrent nasopharyngeal carcinoma from a single center].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Smart nanoplatforms for early detection and immune modulation in lung cancer.Frontiers in bioengineering and biotechnology · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Green synthesis of glyco-CuInSJournal of nanobiotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mehrab PourmadadiSchool of Chemical Engineering, College of Engineering, University of Tehran, Tehran 11155-4563, Iran.ORCID 0000-0002-8819-3649
Ali MoammeriSchool of Chemical Engineering, College of Engineering, University of Tehran, Tehran 11155-4563, Iran.
Amin ShamsabadipourSchool of Chemical Engineering, College of Engineering, University of Tehran, Tehran 11155-4563, Iran.ORCID 0000-0001-9920-4764
Yasamin Farahanian MoghaddamSchool of Chemical Engineering, College of Engineering, University of Tehran, Tehran 11155-4563, Iran.
Abbas RahdarDepartment of Physics, University of Zabol, Zabol 98613-35856, Iran.ORCID 0000-0003-4766-9214
Sadanand PandeyDepartment of Chemistry, College of Natural Science, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic of Korea.ORCID 0000-0003-2065-897X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, diagnosing early-stage cancers can be vital for saving patients and dramatically decreases mortality rates. Therefore, specificity and sensitivity in the detection of cancer antigens should be elaborately ensured. Some early-stage cancers can be diagnosed via detecting the cancer antigen CA-125, such as ovarian cancer, and required treatments can be applied more efficiently. Thus, detection of CA-125 by employing various optical or electrochemical biosensors is a preliminary and crucial step to treating cancers. In this review, a diverse range of optical and electrochemical means of detecting CA-125 are reviewed. Furthermore, an applicable comparison of their performance and sensitivity is provided, several commercial detection kits are investigated, and their applications are compared and discussed to determine whether they are applicable and accurate enough.

Indexed as

Biosensing TechniquesOvarian NeoplasmsCA-125 AntigenFemaleHumansCA-125 Antigencancer antigen 125 detectionelectrochemical nanobiosensorsoptical nanobiosensorsovarian cancer

Identifiers

PMID36671934
PMCPMC9856029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.